Arkema Stock: Shares Up 5.36% Over the Week, Yet Remain Under Pressure
Chemical company Arkema closed the week at 52.45 euros, marking a 5.36% increase over the last five days. This rebound contrasts with the stock's downward trajectory since the start of the year, having plummeted by 29.07% over twelve months. This week, the group's gain slightly surpassed that of the CAC 40 (1.78%) and the SBF 120 (1.87%), indicating some short-term momentum despite a troubled overall context.
Weekly Trading Dynamics
Over the five trading days, Arkema experienced alternating gains and modest declines. The stock opened at 50.65 euros on November 24 and gradually increased to 52.65 euros the following day. The week continued with consolidation around 52 euros, with prices fluctuating between 51.60 and 52.65 euros. Trading volumes showed significant variations, dropping from 4.17 million shares on Monday to less than 300,000 shares on subsequent days, before regaining some vitality towards the end of the period. This weekly performance comes in a year that has been extremely challenging for the stock, which has lost nearly 30% since January 2025. The annual decline reflects the structural challenges faced by the group, characterized by deteriorating profitability. Analysts are projecting a net earnings per share of 4.72 euros for 2025, down from 8.19 euros in 2024, a contraction of nearly 42%. This decline in profitability prospects illustrates the extent of commercial and operational pressures faced by the chemical company.
Technical Perspective
From a technical standpoint, the stock is positioned slightly above its 50-day moving average set at 52.06 euros, while it remains significantly below its 200-day average at 62.15 euros. The Relative Strength Index (RSI) stands at 54, placing the stock in a neutral zone without a strong buy or sell signal. The positive MACD line at 0.18 suggests a nascent bullish momentum, albeit moderate. Bollinger Bands frame the stock between 48.54 and 53.74 euros, with the action evolving at the heart of this range. The technical support threshold is established at 49.02 euros, while resistance is at 53.40 euros. This technical configuration reveals a stock caught between two major levels, with contained monthly volatility at 9.70%. The negative beta of -0.28 indicates a low correlation with the overall market, showing some bearish decorrelation during market tensions.
Analysts' Consensus Price Target
The consensus price target from analysts stands at 63.69 euros, implying an upside potential of 21.43% compared to the current price. However, this target reflects expectations over three months and should be weighed against recent forecast reductions that occurred in November. The company maintains its dividend payment at 3.60 euros per share, offering a yield of 7.08%, a supportive element for investors seeking regular income.
